The FDA changes booster guidance

The FDA made three major decisions this week about Pfizer’s COVID-19 booster vaccination.

Extended Emergency Use authorization

The FDA extended Emergency use authorization for Pfizer’s vaccine approving a vaccine booster for 12–15 year old’s.

timeline to receive a booster

The FDA is shortening the time of completion of the first two doses and the booster to five months instead of the original six months for everyone over the age of 12.

Allowing some children under 12 to receive a booster

The FDA announced they are now allowing a third vaccination for kids 5–11 that are immunocompromised. Kids that fall into this group are children that have had a solid organ transplant or diagnosed with conditions that are equivalent.

As always the CDC needed to sign off on the decisions made by the FDA and they did so Wednesday.

The FDA says if you have any questions about the vaccine and whether your child should get the booster you should always consult your child’s pediatrician.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
BBP News

BBP News

Every week hosts of BBP News Podcast Chris Baker and Nick Rodd write about all current events from politics, technology, business and sports news.